Every year, Gartner publishes the Top 25 Supply Chains which compares all supply chains from across all industries. It’s an unfortunate part of this list, but the performance comparison always draw a lot of attention. The Gartner Supply Chain Top 25 list tries to “balance aspects of product innovation through revenue growth, efficient use of capital through return on assets (ROA), and efficient supply chain practices through inventory turns, balancing the various aspects of Operations that will lead to long term profitability and market performance.”
There is only one pharmaceutical company listed in the top 25 this year, and it’s Johnson & Johnson at the very bottom at number 25. This lack of pharmaceutical supply chains shows that the companies are unable create consistent performance. Why and what can they do to get themselves into a better position? Read more about the benchmarking and analytics, and how pharma companies can create a better supply chain at the green button below.
Keep Reading…